Scientific and clinical research\u2014much of it sponsored by the US government\u2014underscores CBD\u2019s potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere. Further evidence suggests that CBD is safe even at high doses.<\/p>\n

Project CBD responds to inquiries from all over the world. Almost everyone wants to know where to get CBD-rich products and how to use them for maximum benefit. After decades in which only high-THC cannabis was available in North America and beyond, CBD-rich strains and products are now available to medical users.<\/p>\n

\u201cCBD-rich\u201d versus \u201cCBD dominant:\u201d By \u201cCBD-rich,\u201d we mean a cannabis strain or product that has equal amounts of CBD and THC, or more CBD than THC (usually at least 4 percent CBD by dry weight.). By \u201cCBD-dominant,\u201d we mean strains or products that are CBD-rich but have very little THC content.<\/p>\n<\/div>\n\t\n